Journal articles
Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact
Abstract : Artemisinin-based combination therapies (ACTs) are the first-line treatment of uncomplicated malaria. The public health benefit and safety of repeated administration of a given ACT are poorly studied. We conducted a randomized trial comparing artemether-lumefantrine, artesunate plus amodiaquine (AS+AQ) and artesunate plus sulfadoxine-pyrimethamine (AS+SP) in patients 6 months of age and older with uncomplicated malaria in Mali from July 2005 to July 2007. The patient received the same initial treatment of each subsequent uncomplicated malaria episode except for treatment failures where quinine was used. Overall, 780 patients were included. Patients in the AS+AQ and AS+SP arms had significantly less risk of having malaria episodes; risk ratio (RR) = 0.84 (P = 0.002) and RR = 0.80 (P = 0.001), respectively. The treatment efficacy was similar and above 95% in all arms. Although all drugs were highly efficacious and well tolerated, AS+AQ and AS+SP were associated with less episodes of malaria.
Cited literature [20 references]
https://hal-amu.archives-ouvertes.fr/hal-01307775
Contributor : Jean Gaudart Connect in order to contact the contributor
Submitted on : Tuesday, April 26, 2016 - 5:21:26 PM
Last modification on : Tuesday, August 2, 2022 - 3:47:32 AM
Long-term archiving on: : Wednesday, July 27, 2016 - 4:40:14 PM
Contributor : Jean Gaudart Connect in order to contact the contributor
Submitted on : Tuesday, April 26, 2016 - 5:21:26 PM
Last modification on : Tuesday, August 2, 2022 - 3:47:32 AM
Long-term archiving on: : Wednesday, July 27, 2016 - 4:40:14 PM
File
tropmed-87-50.pdf
Explicit agreement for this submission
Licence
Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License